Home
>
National Drug Code (NDC)
>
Adenosine
Adenosine - 25021-301-04 - (Adenosine)
Drug Information of Adenosine
| Product NDC: | 25021-301 |
| Proprietary Name: | Adenosine |
| Non Proprietary Name: | Adenosine |
| Active Ingredient(s): | 3 mg/mL & nbsp; Adenosine |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Adenosine
| Product NDC: | 25021-301 |
| Labeler Name: | Sagent Pharmaceuticals, Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077283 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20071201 |
Package Information of Adenosine
| Package NDC: | 25021-301-04 |
| Package Description: | 10 VIAL in 1 CARTON (25021-301-04) > 4 mL in 1 VIAL |
NDC Information of Adenosine
| NDC Code | 25021-301-04 |
| Proprietary Name | Adenosine |
| Package Description | 10 VIAL in 1 CARTON (25021-301-04) > 4 mL in 1 VIAL |
| Product NDC | 25021-301 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Adenosine |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20071201 |
| Marketing Category Name | ANDA |
| Labeler Name | Sagent Pharmaceuticals, Inc |
| Substance Name | ADENOSINE |
| Strength Number | 3 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Adenosine Receptor Agonist [EPC],Adenosine Receptor Agonists [MoA] |
